================================================================================
EXPERIMENT: l3_audit
INSTANCE: 121
CALCULATOR: Wells' Criteria for Pulmonary Embolism
TIMESTAMP: 2026-01-02T00:32:47.607480
================================================================================

GROUND TRUTH: 1.5
FINAL ANSWER: 1.5
CORRECT: True

NUM STEPS: 2

================================================================================
TRACE
================================================================================

----------------------------------------
STEP 1
----------------------------------------

THOUGHT:
{'content': '<thought>To determine the patient\'s Wells\' criteria for Pulmonary Embolism, I need to extract specific clinical values from the patient note that are relevant to the Wells\' criteria scoring system. The Wells\' criteria include factors such as clinical signs of DVT, heart rate, immobilization, recent surgery or trauma, previous PE/DVT, hemoptysis, and malignancy. I will extract these relevant values from the patient note.</thought>\n\n<action>extract_clinical_values(patient_note="A 68-year-old man presented to the the emergency system with severe dyspnea and hypoxia (SpO2: 87% in ambient air). His past medical history was significant for hypertension, obesity, diabetes, and chronic renal failure. On admission (day 1), he had a temperature of 39°C, high blood pressure (170/100 mmHg), and heart rate (110 bpm in sinus rhythm (SR)). Diffuse breath sounds (rales) were found on both lung fields and the chest HRCT [, Panel E] revealed bilateral GGOs consistent with interstitial inflammatory lung disease. Nasopharyngeal and oropharyngeal swabs were immediately obtained, confirming SARS-CoV-2 positivity. After a CPAP attempt (days 1 and 2), the patient was intubated (day 3) with ventilatory support parameters demonstrating a high (PEEP of 15 cm H2O), FiO2 80%, and driving pressure <15 cmH2O. Serum creatinine increased to 2.3 mg/dL (glomerular filtration rate of 31 mL/min), leukocytes were 8.3 × 109 U/L, lymphocytes were 0.9 × 109 U/L, and hemoglobin was 9.3 g/dL. The high-sensitivity troponin T curve was 59-43–35 ng/L (normal value <14), NT-proBNP reached to 10.650 pg/mL (normal value <153) and C-reactive protein peak was 29 mg/L (normal value <6) with procalcitonin peak of 6.3 ng/mL (normal value range: 0–0.15). Interleuchin-6 values were 91.83 pg/mL and 37.63 pg/mL and he was treated with intravenous tocilizumab. Coagulation markers demonstrated a pro-thrombotic status with a platelet count of 160 × 109 U/L, D-dimer of 17 mcg/mL, fibrinogen of 656 mg/dL, and an aPTT of 33.8 s. ECG [, Panel F] showed atrial fibrillation with high heart rate (111 bpm), mild ST depression, inverted T waves in V4–V6, and a QTc of 437 ms. TTE revealed a moderate left ventricular systolic dysfunction (LVEF 40%) with a mildly dilated left ventricle (end-diastolic diameter of 61 mm), normal right ventricle in size and function, and normal cardiac valves. There was a moderate pericardial effusion, anterior to the right ventricle (maximum 15 mm in diastole). A mobile and elongated (0.3 × 4 cm) clot was noted within the effusion (Panel G). The patient was treated with lopinavir/ritonavir (400 mg BID), hydroxychloroquine (200 mg BID), and enoxaparin (1 mg/kg BID). Metilprednisolone (1 mg/kg OD) was added (day 6) together with beta-blockers, diuretics, and nitrates. Due to persistent atrial fibrillation, enoxaparin was switched to edoxaban (30 mg OD) on day 9. To date (day 15), the clot continues to decrease as seen on the chest HRCT (Panel H). The prone position was used for the first four nights in the ICU. He was extubated the 15th day after intubation; noninvasive ventilation and HFNC were used the following days to optimize oxygenation. At 6-month follow-up, the patient was in good conditions, lung lesions appeared reduced on chest HRCT, but at TTE pericardial clot appeared unchanged []", required_values=["heart rate", "clinical signs of DVT", "immobilization", "recent surgery or trauma", "previous PE/DVT", "hemoptysis", "malignancy"])</action>', 'step_number': 0, 'timestamp': '2026-01-01T23:20:44.548433'}

ACTION:
{'ptool_name': 'extract_clinical_values', 'args': {'patient_note': 'A 68-year-old man presented to the the emergency system with severe dyspnea and hypoxia (SpO2: 87% in ambient air). His past medical history was significant for hypertension, obesity, diabetes, and chronic renal failure. On admission (day 1), he had a temperature of 39°C, high blood pressure (170/100 mmHg), and heart rate (110 bpm in sinus rhythm (SR)). Diffuse breath sounds (rales) were found on both lung fields and the chest HRCT [, Panel E] revealed bilateral GGOs consistent with interstitial inflammatory lung disease. Nasopharyngeal and oropharyngeal swabs were immediately obtained, confirming SARS-CoV-2 positivity. After a CPAP attempt (days 1 and 2), the patient was intubated (day 3) with ventilatory support parameters demonstrating a high (PEEP of 15 cm H2O), FiO2 80%, and driving pressure <15 cmH2O. Serum creatinine increased to 2.3 mg/dL (glomerular filtration rate of 31 mL/min), leukocytes were 8.3 × 109 U/L, lymphocytes were 0.9 × 109 U/L, and hemoglobin was 9.3 g/dL. The high-sensitivity troponin T curve was 59-43–35 ng/L (normal value <14), NT-proBNP reached to 10.650 pg/mL (normal value <153) and C-reactive protein peak was 29 mg/L (normal value <6) with procalcitonin peak of 6.3 ng/mL (normal value range: 0–0.15). Interleuchin-6 values were 91.83 pg/mL and 37.63 pg/mL and he was treated with intravenous tocilizumab. Coagulation markers demonstrated a pro-thrombotic status with a platelet count of 160 × 109 U/L, D-dimer of 17 mcg/mL, fibrinogen of 656 mg/dL, and an aPTT of 33.8 s. ECG [, Panel F] showed atrial fibrillation with high heart rate (111 bpm), mild ST depression, inverted T waves in V4–V6, and a QTc of 437 ms. TTE revealed a moderate left ventricular systolic dysfunction (LVEF 40%) with a mildly dilated left ventricle (end-diastolic diameter of 61 mm), normal right ventricle in size and function, and normal cardiac valves. There was a moderate pericardial effusion, anterior to the right ventricle (maximum 15 mm in diastole). A mobile and elongated (0.3 × 4 cm) clot was noted within the effusion (Panel G). The patient was treated with lopinavir/ritonavir (400 mg BID), hydroxychloroquine (200 mg BID), and enoxaparin (1 mg/kg BID). Metilprednisolone (1 mg/kg OD) was added (day 6) together with beta-blockers, diuretics, and nitrates. Due to persistent atrial fibrillation, enoxaparin was switched to edoxaban (30 mg OD) on day 9. To date (day 15), the clot continues to decrease as seen on the chest HRCT (Panel H). The prone position was used for the first four nights in the ICU. He was extubated the 15th day after intubation; noninvasive ventilation and HFNC were used the following days to optimize oxygenation. At 6-month follow-up, the patient was in good conditions, lung lesions appeared reduced on chest HRCT, but at TTE pericardial clot appeared unchanged []', 'required_values': ['heart rate', 'clinical signs of DVT', 'immobilization', 'recent surgery or trauma', 'previous PE/DVT', 'hemoptysis', 'malignancy']}, 'step_number': 0, 'rationale': '<thought>To determine the patient\'s Wells\' criteria for Pulmonary Embolism, I need to extract specific clinical values from the patient note that are relevant to the Wells\' criteria scoring system. The Wells\' criteria include factors such as clinical signs of DVT, heart rate, immobilization, recent surgery or trauma, previous PE/DVT, hemoptysis, and malignancy. I will extract these relevant values from the patient note.</thought>\n\n<action>extract_clinical_values(patient_note="A 68-year-old man presented to the the emergency system with severe dyspnea and hypoxia (SpO2: 87% in ambient air). His past medical history was significant for hypertension, obesity, diabetes, and chronic renal failure. On admission (day 1), he had a temperature of 39°C, high blood pressure (170/100 mmHg), and heart rate (110 bpm in sinus rhythm (SR)). Diffuse breath sounds (rales) were found on both lung fields and the chest HRCT [, Panel E] revealed bilateral GGOs consistent with interstitial inflammatory lung disease. Nasopharyngeal and oropharyngeal swabs were immediately obtained, confirming SARS-CoV-2 positivity. After a CPAP attempt (days 1 and 2), the patient was intubated (day 3) with ventilatory support parameters demonstrating a high (PEEP of 15 cm H2O), FiO2 80%, and driving pressure <15 cmH2O. Serum creatinine increased to 2.3 mg/dL (glomerular filtration rate of 31 mL/min), leukocytes were 8.3 × 109 U/L, lymphocytes were 0.9 × 109 U/L, and hemoglobin was 9.3 g/dL. The high-sensitivity troponin T curve was 59-43–35 ng/L (normal value <14), NT-proBNP reached to 10.650 pg/mL (normal value <153) and C-reactive protein peak was 29 mg/L (normal value <6) with procalcitonin peak of 6.3 ng/mL (normal value range: 0–0.15). Interleuchin-6 values were 91.83 pg/mL and 37.63 pg/mL and he was treated with intravenous tocilizumab. Coagulation markers demonstrated a pro-thrombotic status with a platelet count of 160 × 109 U/L, D-dimer of 17 mcg/mL, fibrinogen of 656 mg/dL, and an aPTT of 33.8 s. ECG [, Panel F] showed atrial fibrillation with high heart rate (111 bpm), mild ST depression, inverted T waves in V4–V6, and a QTc of 437 ms. TTE revealed a moderate left ventricular systolic dysfunction (LVEF 40%) with a mildly dilated left ventricle (end-diastolic diameter of 61 mm), normal right ventricle in size and function, and normal cardiac valves. There was a moderate pericardial effusion, anterior to the right ventricle (maximum 15 mm in diastole). A mobile and elongated (0.3 × 4 cm) clot was noted within the effusion (Panel G). The patient was treated with lopinavir/ritonavir (400 mg BID), hydroxychloroquine (200 mg BID), and enoxaparin (1 mg/kg BID). Metilprednisolone (1 mg/kg OD) was added (day 6) together with beta-blockers, diuretics, and nitrates. Due to persistent atrial fibrillation, enoxaparin was switched to edoxaban (30 mg OD) on day 9. To date (day 15), the clot continues to decrease as seen on the chest HRCT (Panel H). The prone position was used for the first four nights in the ICU. He was extubated the 15th day after intubation; noninvasive ventilation and HFNC were used the following days to optimize oxygenation. At 6-month follow-up, the patient was in good conditions, lung lesions appeared reduced on chest HRCT, but at TTE pericardial clot appeared unchanged []", required_values=["heart rate", "clinical signs of DVT", "immobilization", "recent surgery or trauma", "previous PE/DVT", "hemoptysis", "malignancy"])</action>', 'raw_action_text': '<action>extract_clinical_values(patient_note="A 68-year-old man presented to the the emergency system with severe dyspnea and hypoxia (SpO2: 87% in ambient air). His past medical history was significant for hypertension, obesity, diabetes, and chronic renal failure. On admission (day 1), he had a temperature of 39°C, high blood pressure (170/100 mmHg), and heart rate (110 bpm in sinus rhythm (SR)). Diffuse breath sounds (rales) were found on both lung fields and the chest HRCT [, Panel E] revealed bilateral GGOs consistent with interstitial inflammatory lung disease. Nasopharyngeal and oropharyngeal swabs were immediately obtained, confirming SARS-CoV-2 positivity. After a CPAP attempt (days 1 and 2), the patient was intubated (day 3) with ventilatory support parameters demonstrating a high (PEEP of 15 cm H2O), FiO2 80%, and driving pressure <15 cmH2O. Serum creatinine increased to 2.3 mg/dL (glomerular filtration rate of 31 mL/min), leukocytes were 8.3 × 109 U/L, lymphocytes were 0.9 × 109 U/L, and hemoglobin was 9.3 g/dL. The high-sensitivity troponin T curve was 59-43–35 ng/L (normal value <14), NT-proBNP reached to 10.650 pg/mL (normal value <153) and C-reactive protein peak was 29 mg/L (normal value <6) with procalcitonin peak of 6.3 ng/mL (normal value range: 0–0.15). Interleuchin-6 values were 91.83 pg/mL and 37.63 pg/mL and he was treated with intravenous tocilizumab. Coagulation markers demonstrated a pro-thrombotic status with a platelet count of 160 × 109 U/L, D-dimer of 17 mcg/mL, fibrinogen of 656 mg/dL, and an aPTT of 33.8 s. ECG [, Panel F] showed atrial fibrillation with high heart rate (111 bpm), mild ST depression, inverted T waves in V4–V6, and a QTc of 437 ms. TTE revealed a moderate left ventricular systolic dysfunction (LVEF 40%) with a mildly dilated left ventricle (end-diastolic diameter of 61 mm), normal right ventricle in size and function, and normal cardiac valves. There was a moderate pericardial effusion, anterior to the right ventricle (maximum 15 mm in diastole). A mobile and elongated (0.3 × 4 cm) clot was noted within the effusion (Panel G). The patient was treated with lopinavir/ritonavir (400 mg BID), hydroxychloroquine (200 mg BID), and enoxaparin (1 mg/kg BID). Metilprednisolone (1 mg/kg OD) was added (day 6) together with beta-blockers, diuretics, and nitrates. Due to persistent atrial fibrillation, enoxaparin was switched to edoxaban (30 mg OD) on day 9. To date (day 15), the clot continues to decrease as seen on the chest HRCT (Panel H). The prone position was used for the first four nights in the ICU. He was extubated the 15th day after intubation; noninvasive ventilation and HFNC were used the following days to optimize oxygenation. At 6-month follow-up, the patient was in good conditions, lung lesions appeared reduced on chest HRCT, but at TTE pericardial clot appeared unchanged []", required_values=["heart rate", "clinical signs of DVT", "immobilization", "recent surgery or trauma", "previous PE/DVT", "hemoptysis", "malignancy"])</action>'}

OBSERVATION:
{'result': {'result': {'extracted': {'heart rate': 110}, 'missing': ['clinical signs of DVT', 'immobilization', 'recent surgery or trauma', 'previous PE/DVT', 'hemoptysis', 'malignancy'], 'notes': 'Heart rate was found in the patient note as 110 bpm. Other required values were not mentioned.'}}, 'success': True, 'error': None, 'step_number': 0, 'execution_time_ms': 1671.313762664795, 'ptool_trace_id': None}

----------------------------------------
STEP 2
----------------------------------------

THOUGHT:
{'content': "<thought>To calculate the Wells' criteria for Pulmonary Embolism, I need to assess the patient's clinical presentation and history based on the following criteria:\n1. Clinical signs of DVT (3 points)\n2. PE is the most likely diagnosis (3 points)\n3. Heart rate > 100 bpm (1.5 points)\n4. Immobilization or surgery in the past 4 weeks (1.5 points)\n5. Previous DVT/PE (1.5 points)\n6. Hemoptysis (1 point)\n7. Malignancy (1 point)\n\nFrom the previous extraction, I have the heart rate (110 bpm), which gives 1.5 points. However, I still need to check for the other criteria. The patient note mentions:\n- No explicit mention of clinical signs of DVT (e.g., swelling, pain, redness in legs).\n- No mention of recent surgery or trauma.\n- No mention of previous PE/DVT.\n- No mention of hemoptysis.\n- No mention of active malignancy.\n\nGiven this, the only applicable criterion is the heart rate > 100 bpm (1.5 points). The other criteria are not met based on the available information.</thought>\n<answer>1.5</answer>", 'step_number': 1, 'timestamp': '2026-01-01T23:20:52.511982'}

ACTION:
None

OBSERVATION:
None


================================================================================
AUDIT & REPAIR
================================================================================

CRITIC VERDICT: repair_needed
CONFIDENCE: 0.725
TOTAL VIOLATIONS: 2
FAILED STEPS: []

AUDIT REPORTS:
  - unknown: pass
  - unknown: pass
  - unknown: pass
  - unknown: fail
      VIOLATION: attempted_calculation - LLM must attempt to call compute_calculation
  - unknown: fail
      VIOLATION: attempted_calculator - LLM must attempt to use compute_calculation

REPAIR SUGGESTIONS:
  1. regenerate_step: step_index=None
     Reason: LLM must attempt to call compute_calculation

REPAIR ATTEMPTS: 1
REPAIR SUCCESS: True
REPAIR ACTIONS TAKEN:
  - RepairAction(action_type=<RepairActionType.REGENERATE_STEP: 'regenerate_step'>, step_index=0, details={'method': 'rewind_and_regenerate'}, reason='LLM must attempt to call compute_calculation; LLM must attempt to use compute_calculation')

